2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
Details for Australian Patent Application No. 2010236027 (hide)
International Classifications
Event Publications
11 November 2010 Complete Application Filed
18 November 2010 Application Open to Public Inspection
Published as AU-B-2010236027
18 August 2011 Application Accepted
Published as AU-B-2010236027
15 December 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2010236028-Methods of Increasing Oral Bioavailability of Tetracyclines
2010236026-Pilot grouping and route protocols in multi-carrier communications systems
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser